SRX HEALTH SOLUTIONS INC (SRXH)
AMEXConsumer StaplesSoftware - ApplicationSnapshot 2026-09-04
$1.51-3.21%
Close 2026-09-04 · 1-day change
AMEXConsumer StaplesSoftware - ApplicationSnapshot 2026-09-04
QuarterlyIQ Insights · SRXH
How strong the business is — where it ranks within its sector on capital efficiency and cash generation, and how well management has been executing.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Continue disciplined capital allocation with share repurchase program and one-time cash dividend to shareholders.
Stated as a priority in 3 quarters including 2026-Q2, 2026-Q1, and 2025-Q4. The company approved a 10 million share repurchase program and declared a one-time cash dividend of $0.05 per share (~$1.3 million aggregate) in 2026-Q2. These capital allocation actions show delivering progress consistent with management's stated priorities.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 2 of the last 3 quarter-over-quarter moves. Historically, Consumer Staples names rated weak grew net income 58% of the time over the next year (vs 56% for the rest of the cohort, n=2094).
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
“Approved a 10 million share repurchase program; declared a one-time cash dividend of $0.05 per share.”
“Entered into Securities Purchase Agreement with accredited investors for capital raising.”
“Announced private placement securities purchase agreement with investors.”
Complete acquisitions and integrate AI-enabled platforms to expand investment and capital allocation capabilities.
Stated in 2 disclosures including 2026-Q2 and a 2026-09-02 press release. The company completed the EMJX acquisition in 2026-Q2 and made a secured debt investment in CERo Therapeutics in 2026-09-02. These actions indicate delivering on M&A and strategic investment priorities.
“Completed the acquisition of EMJX, expanding the Company’s investment and capital allocation capabilities.”
Maintain compliance with NYSE American LLC continued listing standards to ensure listing status.
Stated in 2 disclosures including a 2026-07-16 press release. The company resolved prior deficiencies and regained full compliance with NYSE American listing standards. This shows delivering on regulatory compliance priorities.
Enhance Halo business with improved fill rates, customer growth, and advertising efficiency.
Newly stated in 2026-Q2. Halo operations improved with 98% fill rates and 13% growth in new customers. Net sales increased 27% year over year to $3.4 million in 2026-Q2, indicating delivering progress on operational and customer acquisition improvements.
“Strengthened Halo operations, exiting the quarter with 98% fill rates and record Prime Day performance.”
Complete and integrate acquisition of EMJ Crypto Technologies to expand AI-driven digital asset treasury capabilities.
Over the trailing year it converted 0.53x of net income into operating cash flow.
Not enough signal yet.
Not enough signal to read sensitivity to the US dollar, the broad stock market, real (inflation-adjusted) rates, Fed net liquidity, long-term interest rates (low R² over the window).
41 material management or governance events in the past 24 months, led by M&A activity. Historically, Consumer Staples names rated volatile grew net income 53% of the time over the next year (vs 51% for the rest of the cohort, n=947).
Not investment advice. As of 2026-09-04.